Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
US Department of Justice
QuintilesIMS
Chubb
Federal Trade Commission
Fuji
Dow
McKesson

Generated: April 20, 2018

DrugPatentWatch Database Preview

RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125 Drug Profile

« Back to Dashboard

When do Radioiodinated Serum Albumin (human) Ihsa I 125 patents expire, and when can generic versions of Radioiodinated Serum Albumin (human) Ihsa I 125 launch?

Radioiodinated Serum Albumin (human) Ihsa I 125 is a drug marketed by Mallinckrodt and is included in one NDA.

The generic ingredient in RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125 is albumin iodinated i-125 serum. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the albumin iodinated i-125 serum profile page.
Summary for RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125
Drug patent expirations by year for RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125

US Patents and Regulatory Information for RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125 albumin iodinated i-125 serum INJECTABLE;INJECTION 017844-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinckrodt RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125 albumin iodinated i-125 serum INJECTABLE;INJECTION 017844-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinckrodt RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125 albumin iodinated i-125 serum INJECTABLE;INJECTION 017844-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Argus Health
US Army
Deloitte
US Department of Justice
Queensland Health
Colorcon
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.